Relationship between acetylcholine and cholinesterase activity in the brain following organophosphorus cholinesterase inhibitors.
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002802:Cholinesterases / Q000378:metabolism*; D008294:Malathion / Q000494:pharmacology; D008297:Male; D004849:Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats
D002800:Cholinesterase Inhibitors; D004849:Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester; D010830:Physostigmine; D002802:Cholinesterases; D000109:Acetylcholine; D008294:Malathion